Lili Belcastro

Dr. Lili Belcastro is a Senior Principal Scientist at Bristol-Myers Squibb. She leads the Material Sciences group in Cell Therapy Development. Lili has over fifteen years of experience in preclinical and clinical cancer biology, cell and gene therapy product development, and method development working with a variety of complex biological molecules, small molecule inhibitors, ancillary materials, starting materials, and gene editing materials. Lili holds a PhD in cancer biology from a joint program with the University of the Sciences and The Wistar Institute in Philadelphia.